Literature DB >> 27057149

Plasma transfusions prior to insertion of central lines for patients with abnormal coagulation.

David P Hall1, Lise J Estcourt2, Carolyn Doree3, Sally Hopewell4, Marialena Trivella4, Timothy S Walsh5.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effect of different prophylactic plasma transfusion regimens prior to central line insertion in patients with abnormal coagulation.

Entities:  

Year:  2015        PMID： 27057149      PMCID： PMC4820650          DOI： 10.1002/14651858.CD011756

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  31 in total

Review 1.  The case of the misleading funnel plot.

Authors:  Joseph Lau; John P A Ioannidis; Norma Terrin; Christopher H Schmid; Ingram Olkin
Journal:  BMJ       Date:  2006-09-16

2.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

Authors:  M K Parmar; V Torri; L Stewart
Journal:  Stat Med       Date:  1998-12-30       Impact factor: 2.373

3.  Transfusion-associated circulatory overload after plasma transfusion.

Authors:  Christina Narick; Darrell J Triulzi; Mark H Yazer
Journal:  Transfusion       Date:  2011-07-18       Impact factor: 3.157

Review 4.  Bleeding and coagulopathies in critical care.

Authors:  Beverley J Hunt
Journal:  N Engl J Med       Date:  2014-02-27       Impact factor: 91.245

5.  Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients.

Authors:  Hasrat Khan; Jon Belsher; Murat Yilmaz; Bekele Afessa; Jeffrey L Winters; S Breanndan Moore; Rolf D Hubmayr; Ognjen Gajic
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

6.  Central venous cannulation in patients with liver disease and coagulopathy--a prospective audit.

Authors:  N C Fisher; D J Mutimer
Journal:  Intensive Care Med       Date:  1999-05       Impact factor: 17.440

7.  Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units.

Authors:  Timothy S Walsh; Simon J Stanworth; Robin J Prescott; Robert J Lee; Douglas M Watson; Duncan Wyncoll
Journal:  Crit Care Med       Date:  2010-10       Impact factor: 7.598

Review 8.  The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy.

Authors:  Simon J Stanworth
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

9.  Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection.

Authors:  Babak Sarani; W Jonathan Dunkman; Laura Dean; Seema Sonnad; Jeffrey I Rohrbach; Vicente H Gracias
Journal:  Crit Care Med       Date:  2008-04       Impact factor: 7.598

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279
View more
  3 in total

Review 1.  CIRSE Standards of Practice on Peri-operative Anticoagulation Management During Interventional Radiology Procedures.

Authors:  Mohammed Hadi; Carolina Walker; Michael Desborough; Antonio Basile; Dimitrios Tsetis; Beverley Hunt; Stefan Müller-Hüllsbeck; Thomas Rand; Otto van Delden; Raman Uberoi
Journal:  Cardiovasc Intervent Radiol       Date:  2021-01-20       Impact factor: 2.740

2.  Extracorporeal immune cell therapy of sepsis: ex vivo results.

Authors:  Gerd Klinkmann; Thomas Wild; Benjamin Heskamp; Fanny Doss; Sandra Doss; Lubomir Arseniev; Krasimira Aleksandrova; Martin Sauer; Daniel A Reuter; Steffen Mitzner; Jens Altrichter
Journal:  Intensive Care Med Exp       Date:  2022-06-16

Review 3.  Plasma transfusions prior to insertion of central lines for people with abnormal coagulation.

Authors:  David P Hall; Lise J Estcourt; Carolyn Doree; Sally Hopewell; Marialena Trivella; Timothy S Walsh
Journal:  Cochrane Database Syst Rev       Date:  2016-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.